This study reveals the role of P2RX1 as a calcium-regulated tumor suppressor in Ph+ ALL, promoting apoptosis by disrupting mitochondrial function and inhibiting the PI3K/Akt survival signaling pathway, thereby providing a novel therapeutic approach to overcome TKI resistance. Here, AKT1 is linked to neoplasm.